Our highly qualified and experienced staff develop methods that meet the high standards of FDA and ICH GLP. NCS’s quality driven processes and systems provide for reliable, reproducible and accurate data. NCS has experience with a variety of molecules in different matrices.

Our bioanalytical facility is approximately 10,000 sq. ft.

  • Qualified, trained & experienced team of bioanalytical professionals
  • Method development/validation for proprietary (NCE) and non-proprietary assays
  • Bioanalysis of drug and metabolites in a variety of biological matrices
  • Ability to develop and validate highly sensitive assays in low pg/ml range
  • Ability to accommodate projects with rapid turn-around times
Our Clinical And Bioanalytical Facilities have been inspected/audited by:

FDA, CDSCO (DCGI) India, ANVISA (Brazil), MoH (Turkey), EMA, and WHO.

Instrument details

  • 3 LCMS/MS – API  4000 with WATERS UPLC
  • 3 LCMS/MS – 5500 Triple QUAD and 5500+


  • Analyst 1.7.2 and 1.7.3 for data processing & instrument control
  • Fully validated and 21 CFR (part 11) compliant

We have the latest 5500 LCMS/MS Bio analytical instrument offering very high sensitivity and the ability to conduct hormone studies etc.

Please fill in the below details in order to view the requested content.

Download PDF